Growth hormone - hormone replacement for the somatopause?

Area of Science:

• Endocrinology
• Gerontology
• Metabolic Research

Background:

• Growth hormone (GH) secretion naturally decreases with age, leading to physiological changes similar to GH deficiency.
• Reduced GH levels in older adults correlate with adverse body composition and lipid profiles.

Purpose of the Study:

• To investigate the effects of GH replacement therapy in elderly individuals with diminished GH secretion.
• To evaluate the safety and efficacy of low-dose GH therapy in reversing age-related physiological changes.

Main Methods:

• Review of pioneering studies (Rudman) and subsequent research on GH administration in elderly subjects.
• Analysis of recent studies examining GH effects with or without hormone replacement (testosterone/estrogen).

Main Results:

• GH administration can increase lean body mass, bone density, and improve lipid profiles in the elderly.
• Careful, low-dose GH therapy, tailored to individual needs, shows positive effects on body composition and aerobic capacity.
• Potential synergistic effects observed with combined GH and hormone replacement therapy.

Conclusions:

• Elderly individuals are sensitive to GH, necessitating cautious, individualized dosing strategies.
• GH replacement therapy holds potential for mitigating age-related decline and preventing frailty.
• Further large-scale, placebo-controlled trials are warranted to establish safety and efficacy for widespread clinical use.